Further study clarifying the molecular mechanisms of NLRP3 inflammasome activation would serve to develop a novel therapeutic approach to atherosclerosis and other inflammatory diseases, which are caused by crystals and particulate matter. This evidence concerns the gene NLRP3 and atherosclerosis.